(Q40984962)

English

Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action (English)

1 reference

Europe PubMed Central

25 September 2017

0 references

author name string

Niwayama S

1

1 reference

Europe PubMed Central

25 September 2017

Loh C

2

1 reference

Europe PubMed Central

25 September 2017

Turk BE

3

1 reference

Europe PubMed Central

25 September 2017

Liu JO

4

1 reference

Europe PubMed Central

25 September 2017

Miyachi H

5

1 reference

Europe PubMed Central

25 September 2017

Hashimoto Y

6

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

25 September 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

25 September 2017

8

1 reference

Europe PubMed Central

25 September 2017

1071-1076

1 reference

Europe PubMed Central

25 September 2017

9

1 reference

Europe PubMed Central

25 September 2017

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent inhibition of tumor necrosis factor-alpha production by tetrafluorothalidomide and tetrafluorophthalimides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha production enhancers with a phenylphthalimide skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

(S)-form of alpha-methyl-N(alpha)-phthalimidoglutarimide, but not its (R)-form, enhanced phorbol ester-induced tumor necrosis factor-alpha production by human leukemia cell HL-60: implication of optical resolution of thalidomidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900171-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(98)00171-1

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40984962&oldid=2092868854"